<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04938128</url>
  </required_header>
  <id_info>
    <org_study_id>RS21-008</org_study_id>
    <nct_id>NCT04938128</nct_id>
  </id_info>
  <brief_title>Effect of CPAP vs Control on Nocturnal Dipping in Normotensive Patients With Obstructive Sleep Apnea</brief_title>
  <official_title>The Effect of CPAP on Nocturnal Dipping in Normotensive Patients With Moderate-severe Obstructive Sleep Apnoea, a Multicentre Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St Vincent's University Hospital, Ireland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St Vincent's University Hospital, Ireland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label, parallel, prospective, randomised control trial evaluating the effect&#xD;
      of Continuous Positive airway pressure (CPAP), the standard treatment for obstructive sleep&#xD;
      apnea (OSA) versus control (diet and lifestyle advice) on dipping status and blood pressure&#xD;
      parameters in 100 non-dipper normotensive patients with moderate to severe obstructive sleep&#xD;
      apnea and without established cardiovascular or metabolic disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Dipping status</measure>
    <time_frame>3 months</time_frame>
    <description>Change in % dipping after 3 months of treatment with CPAP versus Control</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the mean 24-hour ambulatory blood pressure (BP)</measure>
    <time_frame>3 months</time_frame>
    <description>Change in mmHg in mean blood pressure from baseline to 12 weeks of treatment compared to control</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure parameters</measure>
    <time_frame>3 months</time_frame>
    <description>Change in mmHg in blood pressure parameters including diurnal and nocturnal systolic blood pressure (SBP) and diastolic blood pressure (DBP) from baseline to 12 weeks of treatment compared to control</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sleep Apnea, Obstructive</condition>
  <arm_group>
    <arm_group_label>CPAP treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will receive CPAP treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group will receive Diet and Lifestyle advice only</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CPAP</intervention_name>
    <description>Gold standard treatment for obstructive sleep apnea. In this group, patients will be prescribed CPAP treatment according to local policy.</description>
    <arm_group_label>CPAP treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Newly diagnosed moderate-severe OSA (by standard criteria)&#xD;
&#xD;
          -  Absence of known hypertension and antihypertensive medication&#xD;
&#xD;
          -  Office blood pressure &lt;140/90mmHg&#xD;
&#xD;
          -  Age 18 - 70 years&#xD;
&#xD;
          -  Able to provide written, informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Previous diagnosis of OSA or previous CPAP treatment&#xD;
&#xD;
          -  Diagnosis of Diabetes Mellitus&#xD;
&#xD;
          -  Active treatment for malignancy or severe psychiatric disorder&#xD;
&#xD;
          -  History of cardiovascular disease or cerebrovascular disease&#xD;
&#xD;
          -  Moderate or severe chronic kidney disease (CKD) defined as a eGFR of ≤ 44mL/min/1.73m2&#xD;
&#xD;
          -  Dipper on ABPM&#xD;
&#xD;
          -  Morbid obesity, defined as BMI ≥40&#xD;
&#xD;
          -  Professional drivers or drivers with a history of road-traffic accident due to&#xD;
             sleepiness&#xD;
&#xD;
          -  Severe excessive daytime sleepiness defined as Epworth sleepiness scale (ESS) &gt;15&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Silke Ryan, PhD, MD</last_name>
    <phone>+35312213702</phone>
    <email>silke.ryan@ucd.ie</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne O' Mahony, MB BCh BAO</last_name>
    <phone>+35312214000</phone>
    <email>anneomahony@svhg.ie</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Vincent's University Hospital</name>
      <address>
        <city>Dublin</city>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Ryan, PhD, MD</last_name>
      <phone>+35312213702</phone>
      <email>silke.ryan@ucd.ie</email>
    </contact>
    <investigator>
      <last_name>Anne M O' Mahony, MB BCh BAO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2021</study_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St Vincent's University Hospital, Ireland</investigator_affiliation>
    <investigator_full_name>Dr Silke Ryan</investigator_full_name>
    <investigator_title>Associate Professor, Consultant in Respiratory and Sleep Medicine</investigator_title>
  </responsible_party>
  <keyword>Continuous positive airway pressure</keyword>
  <keyword>Non-dipper</keyword>
  <keyword>Normotensive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

